<ul><li>New Zealand startup Alimetry has raised US$18 million (A$27m) in a Series A2 round to commercialise its wearable gut health monitoring device for the US market.</li><li>Alimetry's wearable device integrates AI and detects electrical currents from the gut, providing a faster and more accurate diagnostic process for patients with chronic gut symptoms.</li><li>The device has been approved for clinical use by the US Food and Drug Administration and is already being used in over 40 hospitals and clinics globally.</li><li>Alimetry plans to expand its platform to include new features and extend its use beyond the gut, potentially transforming diagnostics in other organs such as the colon.</li></ul>

Kiwi medtech startup Alimetry raises $27 million Series A2 for gut health wearables

Discover more